Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report

Detalhes bibliográficos
Autor(a) principal: Vasconcelos-Santos,Daniel Vítor
Data de Publicação: 2007
Outros Autores: Magalhães,Érika Pacheco, Nehemy,Márcio Bittar
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Arquivos brasileiros de oftalmologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492007000500024
Resumo: PURPOSE: To describe the use of 4 mg intravitreal triamcinolone acetonide (IVTA) for gyrate atrophy-related macular edema (ME) and to report anatomic and functional outcomes, during a nine-month period. CASE REPORT: A 27-year-old female complained of decreased vision since diagnosis of gyrate athrophy (GA), six years before admission. At presentation visual acuity was 20/100 in OD and 20/80 in OS. Ophthalmological examination disclosed significant cataract in OD, pseudophakia in OS and typical GA findings. Fluorescein angiography (FA) disclosed ME that was confirmed by optical coherence tomography (OCT), which also showed subfoveal fluid. OS was treated with a 4-mg IVTA injection. One month later, vision improved to 20/50+1 and foveal thickness decreased, with less leakage in FA. This picture was maintained up to six months, when there was recurrence of ME to a level similar to the baseline. At nine months, visual acuity dropped to 20/80, and ME was maintained, with remodeling in macular profile. CONCLUSION:There is a transient therapeutic effect with 4-mg IVTA injection for GA-related ME. After drug clearance, edema recurs, with return of visual acuity to pretreatment level.
id CBO-2_8fe800cb5a313b2adeab89f023454fb4
oai_identifier_str oai:scielo:S0004-27492007000500024
network_acronym_str CBO-2
network_name_str Arquivos brasileiros de oftalmologia (Online)
repository_id_str
spelling Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case reportGyrate atrophy/drug therapyMacular edema, cystoid/drug therapyTriamcinolone acetonide/therapeutic useCase reportsPURPOSE: To describe the use of 4 mg intravitreal triamcinolone acetonide (IVTA) for gyrate atrophy-related macular edema (ME) and to report anatomic and functional outcomes, during a nine-month period. CASE REPORT: A 27-year-old female complained of decreased vision since diagnosis of gyrate athrophy (GA), six years before admission. At presentation visual acuity was 20/100 in OD and 20/80 in OS. Ophthalmological examination disclosed significant cataract in OD, pseudophakia in OS and typical GA findings. Fluorescein angiography (FA) disclosed ME that was confirmed by optical coherence tomography (OCT), which also showed subfoveal fluid. OS was treated with a 4-mg IVTA injection. One month later, vision improved to 20/50+1 and foveal thickness decreased, with less leakage in FA. This picture was maintained up to six months, when there was recurrence of ME to a level similar to the baseline. At nine months, visual acuity dropped to 20/80, and ME was maintained, with remodeling in macular profile. CONCLUSION:There is a transient therapeutic effect with 4-mg IVTA injection for GA-related ME. After drug clearance, edema recurs, with return of visual acuity to pretreatment level.Conselho Brasileiro de Oftalmologia2007-10-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492007000500024Arquivos Brasileiros de Oftalmologia v.70 n.5 2007reponame:Arquivos brasileiros de oftalmologia (Online)instname:Conselho Brasileiro de Oftalmologia (CBO)instacron:CBO10.1590/S0004-27492007000500024info:eu-repo/semantics/openAccessVasconcelos-Santos,Daniel VítorMagalhães,Érika PachecoNehemy,Márcio Bittareng2007-12-17T00:00:00Zoai:scielo:S0004-27492007000500024Revistahttp://aboonline.org.br/https://old.scielo.br/oai/scielo-oai.phpaboonline@cbo.com.br||abo@cbo.com.br1678-29250004-2749opendoar:2007-12-17T00:00Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)false
dc.title.none.fl_str_mv Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report
title Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report
spellingShingle Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report
Vasconcelos-Santos,Daniel Vítor
Gyrate atrophy/drug therapy
Macular edema, cystoid/drug therapy
Triamcinolone acetonide/therapeutic use
Case reports
title_short Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report
title_full Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report
title_fullStr Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report
title_full_unstemmed Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report
title_sort Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report
author Vasconcelos-Santos,Daniel Vítor
author_facet Vasconcelos-Santos,Daniel Vítor
Magalhães,Érika Pacheco
Nehemy,Márcio Bittar
author_role author
author2 Magalhães,Érika Pacheco
Nehemy,Márcio Bittar
author2_role author
author
dc.contributor.author.fl_str_mv Vasconcelos-Santos,Daniel Vítor
Magalhães,Érika Pacheco
Nehemy,Márcio Bittar
dc.subject.por.fl_str_mv Gyrate atrophy/drug therapy
Macular edema, cystoid/drug therapy
Triamcinolone acetonide/therapeutic use
Case reports
topic Gyrate atrophy/drug therapy
Macular edema, cystoid/drug therapy
Triamcinolone acetonide/therapeutic use
Case reports
description PURPOSE: To describe the use of 4 mg intravitreal triamcinolone acetonide (IVTA) for gyrate atrophy-related macular edema (ME) and to report anatomic and functional outcomes, during a nine-month period. CASE REPORT: A 27-year-old female complained of decreased vision since diagnosis of gyrate athrophy (GA), six years before admission. At presentation visual acuity was 20/100 in OD and 20/80 in OS. Ophthalmological examination disclosed significant cataract in OD, pseudophakia in OS and typical GA findings. Fluorescein angiography (FA) disclosed ME that was confirmed by optical coherence tomography (OCT), which also showed subfoveal fluid. OS was treated with a 4-mg IVTA injection. One month later, vision improved to 20/50+1 and foveal thickness decreased, with less leakage in FA. This picture was maintained up to six months, when there was recurrence of ME to a level similar to the baseline. At nine months, visual acuity dropped to 20/80, and ME was maintained, with remodeling in macular profile. CONCLUSION:There is a transient therapeutic effect with 4-mg IVTA injection for GA-related ME. After drug clearance, edema recurs, with return of visual acuity to pretreatment level.
publishDate 2007
dc.date.none.fl_str_mv 2007-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492007000500024
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492007000500024
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0004-27492007000500024
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
dc.source.none.fl_str_mv Arquivos Brasileiros de Oftalmologia v.70 n.5 2007
reponame:Arquivos brasileiros de oftalmologia (Online)
instname:Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
instname_str Conselho Brasileiro de Oftalmologia (CBO)
instacron_str CBO
institution CBO
reponame_str Arquivos brasileiros de oftalmologia (Online)
collection Arquivos brasileiros de oftalmologia (Online)
repository.name.fl_str_mv Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)
repository.mail.fl_str_mv aboonline@cbo.com.br||abo@cbo.com.br
_version_ 1754209024633470976